CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to test if treatment with tralokinumab is safe and effectful to treat moderate-to-severe atopic hand eczema. Th...
Phase 3
New York, New York, United States and 75 other locations
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Kew Gardens, New York, United States of America and 8 other locations
the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...
Phase 2
Kew Gardens, New York, United States of America and 21 other locations
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Phase 2
Woodbury, New York, United States of America and 6 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
New York, New York, United States and 22 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
New York, New York, United States and 179 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
East Windsor, New Jersey, United States of America and 87 other locations
This is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which co...
Phase 2
New York, New York, United States and 3 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
New York, New York, United States and 83 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
New York, New York, United States and 75 other locations
Clinical trials
Research sites
Resources
Legal